ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

MVA-BN smallpox vaccine

Also written as “IMVAMUNE”, “IMVAMUNE (MVA-BN)” and “IMVAMUNE®”.

Its studies are mostly in Smallpox · Mpox, Monkeypox · Dermatitis, Atopic · HIV Infections, led by 3 companies.

Drug pageMVA-BN smallpox vaccine: every studyAll 31 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Mar 5, 201816 company-led studies, 2 open or runningNext primary completion: Nov 30, 2026 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Bavarian Nordic142 open or runningphase 4since Mar 5, 2018Sep 11, 2005Nov 30, 2026phase 2 · NCT07199569
Johnson & Johnsonits history only10 open or runningearly phase 1since Apr 1, 2019Apr 1, 2019none ahead
Sanofiits history only10 open or runningphase 2since Apr 25, 2007Apr 25, 2007none ahead

Also a collaborator on its studies: ICON.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Bavarian Nordic only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 11, 2005First studies: 2 phase 2 studiesFirst studyNCT00189956, NCT00189904
  2. Sep 11, 20052 phase 1 studiesNCT00189917, NCT00189943
  3. Apr 19, 20063 phase 2 studiesNCT00316589, NCT00316524, NCT00316602
  4. May 27, 2008Phase 2 study in SmallpoxNCT00686582 · 304 enrolled · Germany
  5. Mar 5, 2009Phase 2 study in SmallpoxNCT00857493 · 120 enrolled · United States
  6. Jun 14, 2010Phase 3 study in SmallpoxNCT01144637 · 4,005 enrolled · United States
  7. Jan 15, 2014Phase 2 study in SmallpoxNCT02038881 · 87 enrolled · United States, Puerto Rico
  8. Mar 5, 2018Phase 4 study in VaccinationNCT03472014 · 22 enrolled · United States
  9. Jul 31, 2024Phase 2 study in Mpox, MonkeypoxNCT06549530 · 460 enrolled · Democratic Republic of the Congo, Uganda
  10. Sep 22, 2025Phase 2 study in Mpox, MonkeypoxNCT07199569 · 970 enrolled · United States

Ahead

  1. Nov 30, 2026Primary completion: phase 2 study in Mpox, MonkeypoxNCT07199569

TargetBeta

A vaccine: it acts on a pathogen, not a human gene.

“A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox, ”NCIt, by rule

Studies

All 14 Bavarian Nordic leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07199569Mpox, Monkeypox · United States2Active, not recruitingNov 30, 2026970
NCT06549530Mpox, Monkeypox · Democratic Republic of the Congo, Uganda2Active, not recruitingMay 1, 2026460
NCT03472014Vaccination · United States4CompletedNov 14, 201422
NCT02038881Smallpox · United States, Puerto Rico2CompletedMay 10, 201787
NCT01144637Smallpox · United States3CompletedNov 20134,005
NCT00857493Smallpox · United States2CompletedAug 2010120
NCT00686582Smallpox · Germany2CompletedDec 2008304
NCT00316602Dermatitis, Atopic · United States, Mexico2CompletedNov 2009632
NCT00316589HIV Infections · United States, Puerto Rico2CompletedMar 2009581
NCT00316524Smallpox · Germany2CompletedFeb 2007745
NCT00189943Smallpox · Germany1Completed90
NCT00189956Smallpox · Switzerland2CompletedNov 2003165
NCT00189917Dermatitis, Atopic · Germany1CompletedDec 200560
NCT00189904HIV Infections · United States2Completed151

How it is read

Names in the registry

  • “IMVAMUNE”, 5 entries
  • “IMVAMUNE (MVA-BN)”, 4 entries
  • “IMVAMUNE®”, 3 entries
  • “MVA-BN”, 2 entries
  • “MVA-BN (Quail)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.